Sökning: onr:"swepub:oai:DiVA.org:uu-289194" >
Elevated Levels of ...
Elevated Levels of SOX10 in Serum from Vitiligo and Melanoma Patients, Analyzed by Proximity Ligation Assay
-
- Blokzijl, Andries (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
-
- Chen, Lei, 1985- (författare)
- Uppsala universitet,Molekylära verktyg,Science for Life Laboratory, SciLifeLab
-
- Gustafsdottir, Sigrun M. (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi,Science for Life Laboratory, SciLifeLab
-
visa fler...
-
- Vuu, Jimmy (författare)
- Uppsala universitet,Institutionen för immunologi, genetik och patologi
-
- Ullenhag, Gustav (författare)
- Uppsala universitet,Institutionen för radiologi, onkologi och strålningsvetenskap
-
- Kämpe, Olle (författare)
- Karolinska Institutet,Uppsala universitet,Autoimmunitet
-
- Landegren, Ulf (författare)
- Uppsala universitet,Molekylära verktyg,Science for Life Laboratory, SciLifeLab
-
- Kamali-Moghaddam, Masood (författare)
- Uppsala universitet,Molekylära verktyg
-
- Hedstrand, Håkan (författare)
- Uppsala universitet,Dermatologi och venereologi
-
visa färre...
-
(creator_code:org_t)
- 2016-04-25
- 2016
- Engelska.
-
Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 11:4
- Relaterad länk:
-
https://uu.diva-port... (primary) (Raw object)
-
visa fler...
-
https://journals.plo...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BackgroundThe diagnosis of malignant melanoma currently relies on clinical inspection of the skin surface and on the histopathological status of the excised tumor. The serum marker S100B is used for prognostic estimates at later stages of the disease, but analyses are marred by false positives and inadequate sensitivity in predicting relapsing disorder.ObjectivesTo investigate SOX10 as a potential biomarker for melanoma and vitiligo.MethodsIn this study we have applied proximity ligation assay (PLA) to detect the transcription factor SOX10 as a possible serum marker for melanoma. We studied a cohort of 110 melanoma patients. We further investigated a second cohort of 85 patients with vitiligo, which is a disease that also affects melanocytes.ResultsThe specificity of the SOX10 assay in serum was high, with only 1% of healthy blood donors being positive. In contrast, elevated serum SOX10 was found with high frequency among vitiligo and melanoma patients. In patients with metastases, lack of SOX10 detection was associated with treatment benefit. In two responding patients, a change from SOX10 positivity to undetectable levels was seen before the response was evident clinically.ConclusionsWe show for the first time that SOX10 represents a promising new serum melanoma marker for detection of early stage disease, complementing the established S100B marker. Our findings imply that SOX10 can be used to monitor responses to treatment and to assess if the treatment is of benefit at stages earlier than what is possible radiologically.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)
Nyckelord
- sox10 proximity ligation assay
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
-
PLOS ONE
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas